# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Rocket Pharmaceuticals (NASDAQ:RCKT) has announced an acquisition of Renovacor (AMEX:RCOR) that is expected to be completed in ...
Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway e...
BTIG analyst Yun Zhong downgrades Renovacor (AMEX:RCOR) from Buy to Neutral.
Gainers
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a...
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and su...